title: Management of Rare Histological Types of Breast Tumours.
abstract: Breast tumours exhibit a wide range of morphological phenotypes, and specific histopathological types have particular prognostic and clinical characteristics. The management of uncommon premalignant and malignant lesions is often controversial due to the lack of large single-institution studies or randomised trials to define optimal treatments. In the era of frequent use of treatment guidelines, only a low level of evidence exists for the management of rare histological types of breast tumours. This review is divided into two parts: Firstly, the favourable histological subtypes like tubular, mucinous, medullary breast cancers, and phyllodes tumour (benign, borderline, and malignant) are discussed. The prognosis of these selected lesions is believed to be better than for invasive ductal carcinoma so that in some cases even less aggressive treatment should be considered. Patients with these specific histological types should be informed of this relatively favourable prognosis. Secondly, management recommendations for special situations like Paget's disease (tumour of the nipple) and inflammatory breast carcinoma are presented.
authors.affiliation: Department of Obstetrics and Gynaecology, University of Rostock, Klinikum Suedstadt, Germany.
authors.forename: Toralf
authors.initials: T
authors.lastname: Reimer
references.citation: Breast Cancer Res. 1999;1(1):31-5
references.pmid: 11250680
references.citation: Breast Cancer Res Treat. 2008 Dec;112(3):513-21
references.pmid: 18240020
references.citation: Ann Surg Oncol. 2007 Mar;14(3):1020-3
references.pmid: 17195914
references.citation: Arch Gynecol Obstet. 2008 Feb;277(2):135-8
references.pmid: 17701193
references.citation: J Natl Cancer Inst. 2005 Jul 6;97(13):966-75
references.pmid: 15998949
references.citation: J Clin Oncol. 2008 Mar 1;26(7):1066-72
references.pmid: 18212337
references.citation: Arch Gynecol Obstet. 2004 May;269(4):278-81
references.pmid: 15205980
references.citation: Cancer. 1977 Oct;40(4):1365-85
references.pmid: 907958
references.citation: Cancer. 1996 Feb 15;77(4):697-709
references.pmid: 8616762
references.citation: Cancer Treat Rev. 1988 Mar;15(1):53-63
references.pmid: 3282651
references.citation: Breast Cancer Res Treat. 2007 Apr;102(2):137-42
references.pmid: 17028984
references.citation: Cancer. 2007 Oct 1;110(7):1436-44
references.pmid: 17694554
references.citation: Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1149-54
references.pmid: 16750330
references.citation: Arch Gynecol Obstet. 2007 Dec;276(6):649-53
references.pmid: 17549503
references.citation: Am J Surg. 2002 Dec;184(6):492-8; discussion 498
references.pmid: 12488144
references.citation: Clin Radiol. 2006 May;61(5):423-30
references.pmid: 16679116
references.citation: Ann Oncol. 2007 Jun;18(6):1021-9
references.pmid: 17351259
references.citation: Am J Clin Pathol. 2006 Jul;126(1):55-8
references.pmid: 16753605
references.citation: Cancer. 2000 Oct 1;89(7):1502-11
references.pmid: 11013364
references.citation: J Clin Oncol. 2003 Jun 15;21(12):2254-9
references.pmid: 12805323
references.citation: Semin Diagn Pathol. 2004 Feb;21(1):65-73
references.pmid: 15074561
references.citation: J Surg Oncol. 1995 Mar;58(3):162-7
references.pmid: 7898111
references.citation: Cancer. 2006 Nov 1;107(9):2127-33
references.pmid: 16998937
references.citation: Curr Treat Options Oncol. 2004 Apr;5(2):153-60
references.pmid: 14990209
references.citation: Cancer. 1989 Jun 15;63(12):2532-6
references.pmid: 2541890
references.citation: Ann Surg Oncol. 2005 Jan;12(1):24-8
references.pmid: 15827774
references.citation: Breast Cancer Res Treat. 1990 Oct;16(3):215-29
references.pmid: 2085673
references.citation: Cancer. 1988 Mar 1;61(5):989-96
references.pmid: 2827884
references.citation: Acad Radiol. 2008 Feb;15(2):209-21
references.pmid: 18206620
references.citation: Cancer Treat Rev. 2001 Feb;27(1):9-18
references.pmid: 11237774
references.citation: Breast Cancer Res Treat. 2008 Jun;109(3):417-26
references.pmid: 17653852
references.citation: Am J Surg. 2007 Oct;194(4):527-31
references.pmid: 17826073
references.citation: Ann Surg Oncol. 2007 Oct;14(10):2961-70
references.pmid: 17562113
references.citation: Radiographics. 2003 Jul-Aug;23(4):881-95
references.pmid: 12853663
references.citation: Ann Surg Oncol. 2005 May;12(5):391-7
references.pmid: 15915373
references.citation: Breast Cancer Res Treat. 2005 Oct;93(3):199-205
references.pmid: 16142444
references.citation: J Clin Oncol. 1999 Nov;17(11):3653-63
references.pmid: 10550164
references.citation: J Clin Oncol. 1999 May;17(5):1442-8
references.pmid: 10334529
references.citation: Breast Cancer Res Treat. 2008 Sep;111(2):313-9
references.pmid: 17952590
references.citation: J Clin Pathol. 2008 Jan;61(1):11-9
references.pmid: 17873114
references.citation: Cancer. 1999 Apr 1;85(7):1530-6
references.pmid: 10193943
references.citation: Breast Cancer Res Treat. 2008 Oct;111(3):541-7
references.pmid: 18026874
references.citation: Breast Cancer. 2000 Jan;7(1):65-70
references.pmid: 11029773
references.citation: Br J Cancer. 2007 Oct 8;97(7):883-7
references.pmid: 17876327
references.citation: Int J Cancer. 2007 Jul 1;121(1):127-35
references.pmid: 17330844
references.citation: Eur J Radiol. 2007 Jan;61(1):158-62
references.pmid: 16987629
references.citation: Eur J Radiol. 2000 Jul;35(1):39-43
references.pmid: 10930764
references.citation: Arch Surg. 1999 May;134(5):487-92; discussion 492-3
references.pmid: 10323420
references.citation: J Clin Oncol. 2008 Feb 10;26(5):786-90
references.pmid: 18258987
references.citation: Cancer. 2007 Nov 1;110(9):1929-36
references.pmid: 17896781